Supernus Pharmaceuticals (SUPN) Return on Capital Employed [ROCE] (2012 - 2026)
Supernus Pharmaceuticals (SUPN) recorded Return on Capital Employed [ROCE] of -9.85% in Q2 2026, down 15.79 percentage points from 5.95% a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends
For FY2025, Supernus Pharmaceuticals reported Return on Capital Employed [ROCE] of -5.81%, down 13.73 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has a five-year change of -21.79 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Capital Employed [ROCE] came in at 7.93% in FY2024 (+8.36 pp), -0.44% in FY2023 (-5.02 pp), 4.58% in FY2022 (-2.14 pp) and 6.71% in FY2021 (-9.26 pp).
- The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since Q3 2014.
- On a year-over-year basis, Return on Capital Employed [ROCE] rose in four of the last seven quarters, with an average year-over-year change of -2.25 percentage points.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 8.32 percentage points in Q1 2025, against a drop of 15.79 percentage points in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn | -9.85% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.85% |
| Dec 31, 2025 | -5.67% |
| Sep 30, 2025 | -3.45% |
| Jun 30, 2025 | 5.95% |
| Mar 31, 2025 | 6.93% |
| Dec 31, 2024 | 7.68% |
| Sep 30, 2024 | 5.71% |
| Jun 30, 2024 | 2.65% |
| Mar 31, 2024 | -1.39% |
| Dec 31, 2023 | -0.53% |
| Sep 30, 2023 | 3.00% |
| Jun 30, 2023 | 1.58% |
| Mar 31, 2023 | 4.86% |
| Dec 31, 2022 | 4.57% |
| Sep 30, 2022 | 1.85% |
| Jun 30, 2022 | 5.58% |
| Mar 31, 2022 | 5.42% |
| Dec 31, 2021 | 6.58% |
| Sep 30, 2021 | 9.25% |
| Jun 30, 2021 | 11.65% |
API Access
Supernus Pharmaceuticals Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();